Increases Return News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Company Meets its 2022 Adjusted Guidance After Incorporating the Fourth Quarter Impact of the Biosimilars Transaction and Acquired IPR&D 2023.

United statesAndhra pradeshRajiv malikSanjeev narulaMichael goettlerBiocon biologicsCompany annual report on formViatris incCompany increases return of capital to shareholdersGuidance after incorporatingFourth quarter impactBiosimilars transactionMidpoint reflects revenue growth overExcluding full year impactIncreases returnDirectors approves